{"public_id":"cl_76449a394efc88517c96f513c89bde50","status":"active","superseded_by_public_id":null,"corpus_id":258789608,"text":"DCB-based revascularization was associated with a lower 2-year risk of major adverse cardiovascular events in patients with diabetes, but not in patients without diabetes.","confidence":0.98,"paper":{"corpus_id":258789608,"title":"Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease","url":"https://sah.borca.ai/papers/258789608"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_87bfeea90019a1d6fbb8144eb86e9efa","name":"drug-coated balloon-based revascularization","description":"A percutaneous coronary revascularization strategy using drug-coated balloons alone or combined with drug-eluting stents.","types":["treatment strategy"],"url":"https://sah.borca.ai/concepts/co_87bfeea90019a1d6fbb8144eb86e9efa"},{"public_id":"co_cb403c033693c698a56f59d431722e75","name":"major adverse cardiovascular events","description":"A composite clinical endpoint including cardiac death, myocardial infarction, stroke, thrombosis, target vessel revascularization, and major bleeding.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_cb403c033693c698a56f59d431722e75"},{"public_id":"co_cdf67d9aca9e34ef61ce79b65f0bf0eb","name":"diabetes mellitus","description":"A metabolic disease characterized by chronic hyperglycemia and used here as a subgroup variable.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_cdf67d9aca9e34ef61ce79b65f0bf0eb"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_76449a394efc88517c96f513c89bde50"}